3 results
Approved WMOCompleted
Investigate the effect of adjuvant metformin therapy on insulin need and on glycaemic control in CFRD patients.
Approved WMOCompleted
First, to demonstrate whether UDCA-therapy is effective in reducing total liver volume in PLD patients. Second, we want to assess if UDCA modifies quality of life. Finally, we want to assess safety and tolerability.
Approved WMORecruiting
The aim of this prospective proof-of-concept study is to increase the expression of the SSTR2 in NET patients with negative or low expression to levels amenable for somatostatin analogue treatment through the use of epigenetic drugs.